­
­
­
­

Inventi Impact: Oncology

Articles

  • Inventi:hoc/25108/18
    Radical Gastrectomy: Still the Cornerstone of Curative Treatment for Gastric Cancer in the\nPerioperative Chemotherapy Eraâ??A Single Institute Experience over a Decade
    01-Jan-1970 Research 2018 : April - June
    Harsh Kanhere, Raghav Goel, Ben Finlay, Markus Trochsler, Guy Maddern

    Background and Objectives. Most gastric cancer patients now undergo perioperative chemotherapy (POCT) based on the MAGIC\ntrial results. POCT consists of neoadjuvant chemotherapy (NACT) as well as postoperative adjuvant chemotherapy. This study\nassessed the applicability of perioperative chemotherapy and the impact of radical gastrectomy encompassing a detailed lymphnode\nresection on outcomes of gastric cancer. Methods. Medical and pathology records of all gastric carcinoma resections were\nreviewed from 2006 onwards. Pathological details, number of lymph-nodes resected, and proportion of involved nodes, reasons\nfor nonadministration of NACT, complications, recurrence, and survival data were analysed. Results. Only twenty-eight (37.8%)\nout of 74 patients underwent NACT and only nine completed POCT. NACT was declined due to comorbidities/patient refusal\n

    How to Cite this Article
    CC Compliant Citation: Harsh Kanhere, Raghav Goel, Ben Finlay, Markus Trochsler, and Guy Maddern, â??Radical Gastrectomy: Still the\nCornerstone of Curative Treatment for Gastric Cancer in the Perioperative Chemotherapy Era --A Single Institute Experience over a\nDecade,â? International Journal of Surgical Oncology, vol. 2018, Article ID 9371492, 6 pages, 2018. doi:10.1155/2018/9371492, https://\ncreativecommons.org/licenses/by/4.0/.
    Download Full Text